Home › Cancro al seno › California › Santa Monica
Studi clinici su Cancro al seno a Santa Monica, CA
28 studi su Cancro al seno cercano partecipanti presso sedi a Santa Monica e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
In reclutamentoFase 3
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi di distanza
A Study of PHST001 in Advanced Solid Tumors
In reclutamentoFase 1
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi di distanza
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
In reclutamentoFase 2
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi di distanza
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
In reclutamentoFase 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
In reclutamento
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
In reclutamentoFase 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · a 6 mi di distanza
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
In reclutamentoFase 3
- Clinical Trial Site, Beverly Hills · a 6 mi di distanza
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
In reclutamentoFase 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
In reclutamentoFase 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
In reclutamentoFase 1/2
- Beverly Hills Cancer Center, Beverly Hills · a 6 mi di distanza
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
In reclutamentoFase 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
In reclutamentoFase 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · a 6 mi di distanza
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
In reclutamentoFase 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
In reclutamentoFase 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
In reclutamentoFase 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- e altri 1
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Tower Cancer Research Foundation, Beverly Hills · a 6 mi di distanza
- Cedars-Sinai Cancer - Tarzana, Tarzana · a 11 mi di distanza
- Kaiser Permanente-Woodland Hills, Woodland Hills · a 12 mi di distanza
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
In reclutamentoFase 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · a 6 mi di distanza
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
In reclutamentoFase 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · a 11 mi di distanza
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
In reclutamentoFase 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
In reclutamentoFase 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · a 12 mi di distanza
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · a 4 mi di distanza
- Precision NextGen Oncology & Research Center, Beverly Hills · a 6 mi di distanza
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
In reclutamentoFase 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
In reclutamentoFase 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
In reclutamentoFase 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · a 11 mi di distanza
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
In reclutamentoFase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
In reclutamentoStudio osservazionale
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Studi su Cancro al seno in altre città
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Santa Monica
- Cancro del polmone non a piccole cellule45 studi
- Cancro colorettale23 studi
- Cancro (tutti i tipi)22 studi
- Cancro metastatico19 studi
- Cancro ai polmoni15 studi
- Cancro ovarico15 studi
- Cancro alla prostata15 studi
- Carcinoma a cellule squamose della testa e del collo13 studi
- Insufficienza cardiaca11 studi
- Cancro dell'endometrio10 studi
- Cancro dello stomaco9 studi
- Cancro pancreatico9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.